UPDF AI

Whole genome characterisation of Enterotoxigenic Escherichia coli circulating in Zambia

Suwilanji Silwamba,Michelo Simuyandi,17 Authors,Astrid von Mentzer

2025 · DOI: 10.1101/2025.02.20.25322610
medRxiv · 0 Citations

TLDR

The genomic diversity of ETEC in Zambia is highlighted, revealing concerns about multidrug resistance and identifying virulence profiles, which reiterate the urgent need for enhanced surveillance and targeted interventions, including vaccine development, to combat ETEC-related diarrhoea effectively.

Abstract

Background Enterotoxigenic Escherichia coli (ETEC) is a significant cause of diarrheal disease, particularly in low--and middle-income countries, including Zambia. ETEC pathogenesis is driven by colonisation factors (CF) and enterotoxins, and increasing antimicrobial resistance compounds the global health burden. Despite its impact, limited genomic data exists for ETEC strains in Sub-Saharan Africa. Methods This study conducted whole-genome sequencing of 62 ETEC isolates collected from children under five years old presenting with moderate-to-severe diarrhoea in Lusaka, Zambia. Genomic DNA was extracted, sequenced using the Illumina MiSeq platform, and analysed for phylogenetic relationships, toxin profiles, CF combinations, AMR genes, and plasmid incompatibility groups. Sequences were processed using bioinformatics tools, including SPAdes for genome assembly and Abricate for virulence and AMR profiling. Results The isolates displayed diverse phylogenetic groupings, predominantly within phylogroups A (22 isolates) and B1 (29 isolates). Forty-five serotypes and 39 sequence types were identified, with ST155, ST4, and ST847 being most prevalent. 35% of isolates lacked a known CF, but CS6-only stains were the most common (8%). The most frequent toxin profile was LTh (31%); AMR analysis revealed 350 resistance genes, with Sul2 (14%) and blaTEM-1 (10%) being predominant. ~89% of isolates exhibited genomic multidrug resistance. Plasmid analysis identified IncFII as the most prevalent incompatibility group (19%). Conclusion This study highlights the genomic diversity of ETEC in Zambia, revealing concerns about multidrug resistance and identifying virulence profiles. These findings reiterate the urgent need for enhanced surveillance and targeted interventions, including vaccine development, to combat ETEC-related diarrhoea effectively.